Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Short term Debt (2019 - 2025)

Pulmonx has reported Short term Debt over the past 7 years, most recently at $106000.0 for Q4 2025.

  • Quarterly Short term Debt fell 96.66% to $106000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $106000.0 through Dec 2025, down 96.66% year-over-year, with the annual reading at $106000.0 for FY2025, 96.66% down from the prior year.
  • Short term Debt was $106000.0 for Q4 2025 at Pulmonx, up from $105000.0 in the prior quarter.
  • Over five years, Short term Debt peaked at $7.8 million in Q1 2025 and troughed at $90000.0 in Q4 2022.
  • The 5-year median for Short term Debt is $289000.0 (2021), against an average of $1.7 million.
  • Year-over-year, Short term Debt tumbled 98.2% in 2023 and then soared 5648.35% in 2024.
  • A 5-year view of Short term Debt shows it stood at $91000.0 in 2021, then decreased by 1.1% to $90000.0 in 2022, then soared by 2294.44% to $2.2 million in 2023, then surged by 47.38% to $3.2 million in 2024, then crashed by 96.66% to $106000.0 in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Short term Debt are $106000.0 (Q4 2025), $105000.0 (Q3 2025), and $104000.0 (Q2 2025).